Chinese medicinal composition for treating chloasma
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and technology for chloasma, applied in the directions of drug combination, pharmaceutical formula, plant raw material, etc., can solve the problems of unsatisfactory curative effect, easy recurrence, and insignificant curative effect, etc., achieve good therapeutic effect, promote skin metabolism, and regulate endocrine. Effect
Inactive Publication Date: 2012-02-01
黄细刚
View PDF0 Cites 6 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
At present, the internal medicines and external medicines used to treat chloasma...
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0031] Internal medicine:
[0032] 6.5 parts of Angelica, 6 parts of Salvia, 6.5 parts of Bupleurum, 6.5 parts of Poria, 6 parts of Comfrey, 6.5 parts of Alisma, 6.5 parts of winter melon kernel, 6.5 parts of Angelica dahurica, 6.5 parts of Ling Xiaohua, 6.5 parts of rose, 6.5 parts of hibiscus, 6.5 parts of lotus, 6.5 parts of peach blossom, 6.5 parts of bletilla striata, 6.5 parts of Chinese yam, 3.5 parts of safflower, 3.5 parts of licorice;
[0033] External use:
[0034] 20 parts of bletilla striata, 20 parts of angelica dahurica, 10 parts of safflower, 15 parts of salvia miltiorrhiza.
Embodiment 2
[0036] Internal medicine:
[0037] 9.5 parts of Angelica, 9.5 parts of Salvia, 9.5 parts of Bupleurum, 15 parts of Poria, 9 parts of Comfrey, 15 parts of Alisma, 9.5 parts of winter melon kernel, 9.5 parts of Angelica dahurica, 9.5 parts of Lingxiao flower, 9.5 parts of rose, 9.5 parts of hibiscus, 9.5 parts of lotus, 9.5 parts of peach blossom, 9.5 parts of bletilla striata, 15 parts of Chinese yam, 6.5 parts of safflower, 6.5 parts of licorice;
[0038] External use:
[0039] 40 parts of Bletilla striata, 40 parts of Angelica dahurica, 20 parts of safflower, and 30 parts of Danshen.
Embodiment 3
[0041] Internal medicine:
[0042] 8 parts of Angelica, 8 parts of Salvia, 8 parts of Bupleurum, 10.5 parts of Poria, 9 parts of Comfrey, 10.5 parts of Alisma, 8 parts of winter melon kernel, 8 parts of Angelica dahurica, 8 parts of Lingxiao flower, 8 parts of rose, 8 parts of hibiscus; 8 parts of lotus, 8 parts of peach blossom, 8 parts of bletilla striata, 10.5 parts of Chinese yam, 5 parts of safflower, 5 parts of licorice;
[0043] External use:
[0044] 30 parts of Bletilla striata, 30 parts of Angelica dahurica, 15 parts of safflower, and 23 parts of Danshen.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a Chinese medicinal composition for treating chloasma. The Chinese medicinal composition comprises an oral medicine and an externally applied medicine. The oral medicine consists of the following powdery Chinese herbal medicines in part by weight: 6.5 to 9.5 parts of Angelica sinensis, 6 to 9.5 parts of root of red-rooted salvia, 6.5 to 9.5 parts of bupleurum chinense, 6.5to 15 parts of tuckahoe, 6 to 9 parts of sinkiang arnebia root, 6.5 to 15 parts of alisma plantagoaquatica, 6.5 to 9.5 parts of wax gourd seed, 6.5 to 9.5 parts of angelica dahurica, 6.5 to 9.5 partsof Chinese trumpet creeper, 6.5 to 9.5 parts of rose, 6.5 to 9.5 parts of hibiscus, 6.5 to 9.5 parts of lotus, 6.5 to 9.5 parts of peach blossom, 6.5 to 9.5 parts of bletilla striata, 6.5 to 15 partsof Chinese yam, 3.5 to 6.5 parts of safflower, and 3.5 to 6.5 parts of liquorice; and the externally applied medicine consists of the lowing Chinese herbal medicines in part by weight: 20 to 40 partsof bletilla striata, 20 to 40 parts of angelica dahurica, 10 to 20 parts of safflower, and 15 to 30 parts of root of red-rooted salvia. The invention has the advantages that: chloasma is treated by combining the oral medicine and the externally applied medicine, and the Chinese medicinal composition has a better treatment effect than a single medicine.
Description
technical field [0001] The invention belongs to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition for treating chloasma. Background technique [0002] Chloasma disease is a common multiple disease, which occurs in facial pigmentation disease, which affects the appearance very much, especially in women, and more than 70% of the population in my country suffers from it. The onset is related to internal injuries of the seven emotions, stagnation of liver qi, fatigue from diet, liver and kidney deficiency, and irregular menstrual blood in women. At present, the internal medicines and external medicines used to treat chloasma are mainly vitamins and hormones, and none of them have satisfactory curative effects. Some of them are effective during the medication period, and they are prone to relapse after stopping the medication, and some of them have no significant curative effect, etc. . Contents of the invention [0003] T...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more